Neonicotinoids
target nicotinic acetylcholine receptors (nAChRs) in the insect central nervous system.
To some extent, all of these medications, which are approved by the FDA,
all target the nicotinic receptor in the brain, and this might not be the optimal strategy for women.
It targets nicotinic 42 receptors (see «Mixed signals»), which normally receive chemical signals from the neurotransmitter acetylcholine.
Not exact matches
Abstract Pentameric channel - receptors, including
nicotinic acetylcholine, glycine and GABAA receptors, play a key role in fast excitatory and inhibitory transmission in the nervous system and are the
target of numerous therapeutic and addictive drugs.
Presynaptic type III neuregulin1 - ErbB signaling
targets α7
nicotinic acetylcholine receptors to axons.
Presynaptic
targeting of α4β2
nicotinic acetylcholine receptors is regulated by neurexin - 1β.
«It raises the possibility that
nicotinic receptors may be important
targets for the treatment of multiple addictions, not just nicotine.
Objective: To study, at high spatial and temporal resolution, the conformational dynamics of the
nicotinic receptors enabling neuronal communication in the brain, which are major therapeutic
targets linked to cognition and tobacco dependence.